Comparison of pembrolizumab dosing regimens and incidence and severity of immune-related adverse effects: A retrospective, case-control study.

Saved in:
Bibliographic Details
Title: Comparison of pembrolizumab dosing regimens and incidence and severity of immune-related adverse effects: A retrospective, case-control study.
Authors: Monson T; The University of Kansas Cancer Center, Westwood, KS, USA., Cascone VJ; The University of Kansas Cancer Center, Westwood, KS, USA., Diaz FJ; Department of Biostatistics and Data Science, The University of Kansas Medical Center, Kansas City, KS, USA., Dai J; Department of Biostatistics and Data Science, The University of Kansas Medical Center, Kansas City, KS, USA., Doolittle GC; The University of Kansas Cancer Center, Westwood, KS, USA.
Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2026 Apr 06. Date of Electronic Publication: 2026 Apr 06.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-2900 (Electronic) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first